The key questions that were discussed throughout this program were:
- Under the AIA’s inter partes review, who bears the burden of proof for demonstrating unpatentability?
- Under which sections of the Patent Act can challenges be brought to inter partes review?
- What are the timelines for filing petitions for inter partes review? What are the fees?
- What are the criteria for granting petitions for inter partes review?
- To what extent do Federal Rules of Evidence apply to inter partes review?
- How does the filing of Declaratory Judgment affect rights to pursue inter partes review?
- When is estoppel triggered in the context of inter partes review?
- How do discovery and Markman hearings in the context of inter partes review compare to traditional litigation?
- How do stays work with regard to inter partes review?
- How can failed patent challenges in inter partes review lead to a greater likelihood of the determination of willful infringement?
- To what extent do intervening rights exist for new claims incorporated into patents after inter partes review ?
Click here to learn more about this program.
Related Insights
July 14, 2025
Health Care Law Today
FDA: Commissioner’s National Priority Voucher Program Aims to Streamline Some Drug Reviews
The U.S. Food and Drug Administration (FDA) recently announced a new Commissioner’s National Priority Voucher (CNPV) program, via a press…
July 11, 2025
Foley Viewpoints
Department of Justice Launches Program to Reward Antitrust Whistleblowers with Shares of Criminal Fines
On July 8, 2025, the U.S. Department of Justice, Antitrust Division (“Antitrust Division”) announced a new “Whistleblower Rewards…
July 23, 2025
Events
Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact
Foley partner Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, is speaking in Strafford’s upcoming webinar titled “Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact” on July 23.